Navigation Links
A CNIO research team discovers new regulators of the most prevalent liver disease
Date:1/7/2014

Excessive alcohol consumption, as well as obesity leads to the accumulation of fat in the liver, a disease termed fatty liver disease (FLD) or steatosis. FLD is one of the most prevalent diseases in Western societies and affects about 30% of the adult population. Importantly, FLD increases the risk of liver failure, diabetes and cancer and no pharmacological therapies exist for this detrimental disease.

The Genes, Development and Disease research team led by Erwin Wagner, head of the BBVA Foundation-Spanish National Cancer Research Centre (CNIO) Cancer Cell Biology Programme, in collaboration with Johan Auwerx from the EPFL in Lausanne, have discovered novel factors, the AP-1 proteins, which are critically involved in FLD pathogenesis. These results are featured on the cover of the latest issue of Cell Metabolism, the leading journal in the field of metabolism.

The CNIO team found that the AP-1 gene Fra-1 is reduced in the liver of obese mice. To study the functional contribution of these proteins to fat metabolism in the liver, researchers used transgenic mice with increased or decreased AP-1 expression in the liver.

Strikingly, increased expression of some of these genes, such as Fra-1 or Fra-2, in the liver of mice completely prevented the accumulation of fat and FLD. "In humans, unhealthy diet is the main cause of FLD. Therefore, we used a fat-rich diet to induce obesity and FLD in mice. When we switched on Fra-1 in the liver, all the fat disappeared, the effect was stunning", states first author Sebastian Hasenfuss. In addition, Fra-1 also prevented inflammation and liver damage in obese mice.

The CNIO researchers describe the mechanism underlying the effect of AP-1 proteins on fat metabolism. "AP-1 proteins are master regulators of fat metabolism", explains corresponding author Erwin Wagner. He adds that "these proteins control how the liver takes up fat from the blood stream."

Interestingly, the AP-1 proteins c-Fos or JunD, which are related to the Fra proteins, had the opposite effect on fat metabolism in the liver. The CNIO research team proposes that the imbalance between the different AP-1 proteins represents a key step in FLD pathogenesis.


'/>"/>
Contact: Nuria Noriega
comunicacion@cnio.es
Centro Nacional de Investigaciones Oncologicas (CNIO)
Source:Eurekalert

Related biology news :

1. MU researchers study of African forest elephants helps guide research efforts in the US
2. The 5 fingers of our feathered friends: New research results on the evolution of bird wings
3. Updating air pollution measurement methods with air quality, health effects research
4. New organization brings together top researchers to sequence the genomes of invertebrates
5. Autism Speaks awards nearly $2.7 million for new research projects
6. UT Arlington research may unlock enzymes role in disease
7. Montana State University research on algal biofuels keys larger study
8. Study finds patients give broad endorsement to stem cell research
9. Finnish research team reveals how emotions are mapped in the body
10. Plan to delist gray wolf endangers other threatened species, researchers find
11. Researchers say fructose does not impact emerging indicator for cardiovascular disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2016)... LONDON , June 2, 2016 ... Systems, Manned Platforms, Unmanned Systems, Physical Infrastructure, Support & ... intelligence provider visiongain offers comprehensive analysis of ... that this market will generate revenues of $17.98 billion ... Systems acquired DVTEL Inc, a leader in software and ...
(Date:5/16/2016)... NEW YORK , May 16, 2016   ... authentication solutions, today announced the opening of an IoT ... to strengthen and expand the development of embedded ... provides an unprecedented level of convenience and security with ... to authenticate one,s identity aside from DNA. EyeLock,s platform ...
(Date:4/28/2016)... India , April 28, 2016 ... Infosys (NYSE: INFY ), and Samsung SDS, a ... that will provide end customers with a more secure, ... services.      (Logo: http://photos.prnewswire.com/prnh/20130122/589162 ) , ... services, but it also plays a fundamental part in enabling ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... 2016   Boston Biomedical , an industry ... to target cancer stemness pathways, announced that its ... Drug Designation from the U.S. Food and Drug ... including gastroesophageal junction (GEJ) cancer. Napabucasin is an ... cancer stemness pathways by targeting STAT3, and is ...
(Date:6/23/2016)... SANTA MONICA, Calif. , June 23, 2016  The Prostate Cancer ... to pioneer increasingly precise treatments and faster cures for prostate cancer. Members of ... 77 institutions across 15 countries. Read More About the ... ... ...
(Date:6/23/2016)... ... June 23, 2016 , ... In a new case report published ... how a patient who developed lymphedema after being treated for breast cancer benefitted from ... the paradigm for dealing with this debilitating, frequent side effect of cancer treatment. ...
(Date:6/23/2016)... ... June 23, 2016 , ... ClinCapture, the ... Convention Center and will showcase its product’s latest features from June 26 to ... a scientific poster on Disrupting Clinical Trials in The Cloud during the conference. ...
Breaking Biology Technology: